OxyContin

Four companies say they’ll move ahead with a $26 billion settlement of lawsuits over the opioid crisis.

A landmark settlement in the nation’s opioid epidemic is forcing the owners of OxyContin maker Purdue Pharma to give up the company and pay out $4.5 billion

A federal bankruptcy judge has approved with conditions a historic opioid settlement between Purdue Pharma and thousands of local and state governments

A Purdue Pharma lawyer says states would get more money from settling with the company than if they were allowed to continue their lawsuits against the OxyContin maker and members of the Sackler family who own it

A lawyer for Purdue Pharma says the company’s settlement plan is the only way to avoid long and expensive litigation.

Former Purdue Pharma president and chair Richard Sackler says he, his family and the company do not have any responsibility for the opioid crisis in the United States

A member of the family that owns Purdue Pharma has told a court that the family will not contribute billions to abate the U.S. opioid crisis unless it is granted protection from current and future lawsuits

More than a dozen states have dropped their objections to OxyContin maker Purdue Pharma’s reorganization plan, edging the company closer to resolving its bankruptcy case.

OxyContin maker Purdue Pharma has a $10 billion plan to transform into a new company dedicated to fighting the opioid crisis, but its not a done deal yet

Two members of the Sackler family that owns OxyContin maker Purdue Pharma have acknowledged the drug had a role in the opioid epidemic

Purdue Pharma, the manufacturer of the painkiller Oxycontin, pleaded guilty to charges for its role in the opioid crisis. 

Purdue Pharma says its guilty plea over its role in the opioid crisis is “an essential step to preserve billions of dollars” for the settlement it is pursuing in bankruptcy court

A bankruptcy judge has given his approval to OxyContin maker Purdue Pharma’s $8 billion settlement with the U.S. Department of Justice.

NYU Langone Medical Center will remove the family name Sackler from its biomedical institute after the Sackler’s company, Purdue Pharma, agreed to plead guilty to criminal charges for marketing the addictive prescription painkiller OxyContin that experts say helped touch off an opioid epidemic. “In view of yesterday’s U.S. Department of Justice announcement of the settlement of federal criminal charges with Purdue...

The Department of Justice announced Wednesday that Purdue Pharma agreed to plead guilty to criminal charges for their marketing of OxyContin.

The Department of Justice announced Wednesday that Purdue Pharma agreed to plead guilty to criminal charges for their marketing of OxyContin.

The Justice Department says Purdue Pharma, the company that makes OxyContin, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion. OxyContin is the powerful prescription painkiller that experts say helped touch off an opioid epidemic. The charges include conspiracy to defraud the United States and violating federal anti-kickback laws. The deal...

Victims of opioid addiction weren’t in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company’s role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by addiction have important seats at the table — and could force fundamental changes to...

Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of Purdue Pharma’s offer to settle thousands of lawsuits over the nation’s opioid crisis in court filings that also said the company had funneled up to $13 billion to its controlling family. Their legal filings said the tentative deal does...

Attorneys for some 2,000 local governments say they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation’s opioid crisis.